## Personalized Spine Surgery Gets New Player: Carlsmed's Cervical Innovation Changes ACDF Surgery Landscape
Carlsmed (NASDAQ: CARL) just made a major push into the cervical fusion market with its Aprevo platform, unveiling what could reshape how spine surgeons approach customization. The breakthrough came at the Cervical Spine Research Society's 53rd Annual Meeting in Washington, D.C., where the company showcased early clinical wins and highlighted a critical market opportunity: the U.S. performs roughly 370,000 cervical fusion procedures annually.
What makes this different? Instead of relyin
Carlsmed (NASDAQ: CARL) just made a major push into the cervical fusion market with its Aprevo platform, unveiling what could reshape how spine surgeons approach customization. The breakthrough came at the Cervical Spine Research Society's 53rd Annual Meeting in Washington, D.C., where the company showcased early clinical wins and highlighted a critical market opportunity: the U.S. performs roughly 370,000 cervical fusion procedures annually.
What makes this different? Instead of relyin